Pharmaceutical and biotech companies realize the importance of educating the payer sector to improve the likelihood of a successful launch of their new products. As payers’ influence in the marketplace has grown, so has the importance of effective payer education tactics- no more so than in the diabetes therapeutic area where competition is fierce for prime formulary positioning. This Best Practices®, LLC benchmarking study provides benchmarks around timing of payer-oriented market education and effective education tactics for payers.
This document provides information about the 3rd Annual Medical Device Business Development conference taking place January 30-31, 2017 in Atlanta, GA. The conference will focus on mergers, acquisitions, and corporate strategy within the medical device industry. Over 23 industry leaders from companies such as Johnson & Johnson, Medtronic, and Stryker will present on topics including identifying potential business development targets, assessing risk, negotiating deals, and balancing organic and inorganic growth strategies. The agenda includes keynote panels, case studies, and group discussions. The conference aims to provide networking and idea sharing opportunities for medical device business development executives.
This document provides an agenda for a conference on comparative effectiveness of health interventions. The conference will feature nearly 25 experts who will discuss issues related to developing and using comparative effectiveness data to change healthcare policy and practice. Speakers will address how technologies are evaluated and paid for, and how outcomes are determined. Breakout sessions will explore topics like what data is available now for comparative effectiveness studies, and if consumers can effectively use comparative effectiveness information. Federal agencies, states, private insurers, businesses, and providers will discuss their roles and what changes are needed to increase the use of comparative effectiveness in decision making.
The 3rd Annual Investigator Initiated and Sponsored Research conference will take place January 21-22, 2015 in Philadelphia, PA. The conference will provide insights from industry leaders on building standards for determining fair market value, transparency, and reporting practices for investigator initiated studies, investigator sponsored trials, and cooperative group research. Participants can choose from in-depth workshops, breakout sessions, and think tanks on optimizing global research, conducting fair market value analysis, leveraging master protocols, and developing tactics for negotiating investigator initiated study agreements. The goal is to create a platform for developing standards in these important areas of clinical research.
Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...Best Practices
With the shift toward evidence-based medicine and value-based pricing, many bio-pharmaceutical companies are transitioning their Health Economics and Outcomes Research (HEOR) function away from the Commercial organization to Medical Affairs. This has some major implications towards the interactions with key stakeholders, the way interactions are documented and the skill sets & activities that may be required. Development of strong health outcomes capabilities within Medical Affairs organizations requires an increase in that function’s involvement with health outcomes groups, development of field-based health outcomes capabilities, customization of health outcomes data by stakeholders and building real world data capabilities to generate and utilize health outcomes information.
Best Practices, LLC undertook this study to identify strategies to increase MA’s role in Health Outcomes data generation and utilization. Specifically, the study highlights the role of Medical Affairs function in HO activities, industry drivers and resource levels for HO groups, challenges of MA’s involvement in HO activities and strategies for effective HO data communication and utilization.
Download Full Report: http://bit.ly/2dGFAbz
This document summarizes a report that investigated student opinions and attitudes towards adding an Event Marketing minor to the Welch College of Business at Sacred Heart University. A survey and focus group were conducted. The results showed that over half of students were interested in event marketing as a career. The report concluded most students would enroll in the minor. It was recommended that the Welch College of Business offer this minor, as it would provide a competitive advantage for students and increase enrollments for the university. The minor would expand academic offerings and expertise for students.
1. The document analyzes whether Sacred Heart University's College of Business should offer a minor in event marketing.
2. It conducted a survey and focus group of Sacred Heart students to understand their interest and opinions on adding this minor.
3. The results found that over half (56.9%) of students were interested in event marketing as a career and minor. It was recommended that the college offer this minor given the clear student interest.
This document discusses the importance of research in business management and decision making. It provides several examples of how businesses use research, including testing new products, measuring advertising effectiveness, ensuring adequate distribution, studying competitors, and recruiting qualified employees. The document also explains that research helps businesses make informed decisions, identify customer needs and preferences, analyze industry trends, and evaluate processes for improved efficiency. Overall, the document emphasizes that research is vital for businesses of all sizes to gain insights, remain competitive, and make strategic decisions.
This document provides tips and strategies for successful research participant recruitment, with a focus on recruiting underrepresented populations. It emphasizes the importance of preparing early in the research process by setting realistic recruitment goals, understanding the target population's perspective and priorities, and developing community partnerships. Specific strategies discussed include tailoring communications and the study design to the population, using various platforms like social media for outreach, addressing potential barriers to participation, and maintaining high retention through ongoing communication and convenience. The document also provides examples of recruitment materials and study summaries.
This document provides information about the 3rd Annual Medical Device Business Development conference taking place January 30-31, 2017 in Atlanta, GA. The conference will focus on mergers, acquisitions, and corporate strategy within the medical device industry. Over 23 industry leaders from companies such as Johnson & Johnson, Medtronic, and Stryker will present on topics including identifying potential business development targets, assessing risk, negotiating deals, and balancing organic and inorganic growth strategies. The agenda includes keynote panels, case studies, and group discussions. The conference aims to provide networking and idea sharing opportunities for medical device business development executives.
This document provides an agenda for a conference on comparative effectiveness of health interventions. The conference will feature nearly 25 experts who will discuss issues related to developing and using comparative effectiveness data to change healthcare policy and practice. Speakers will address how technologies are evaluated and paid for, and how outcomes are determined. Breakout sessions will explore topics like what data is available now for comparative effectiveness studies, and if consumers can effectively use comparative effectiveness information. Federal agencies, states, private insurers, businesses, and providers will discuss their roles and what changes are needed to increase the use of comparative effectiveness in decision making.
The 3rd Annual Investigator Initiated and Sponsored Research conference will take place January 21-22, 2015 in Philadelphia, PA. The conference will provide insights from industry leaders on building standards for determining fair market value, transparency, and reporting practices for investigator initiated studies, investigator sponsored trials, and cooperative group research. Participants can choose from in-depth workshops, breakout sessions, and think tanks on optimizing global research, conducting fair market value analysis, leveraging master protocols, and developing tactics for negotiating investigator initiated study agreements. The goal is to create a platform for developing standards in these important areas of clinical research.
Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...Best Practices
With the shift toward evidence-based medicine and value-based pricing, many bio-pharmaceutical companies are transitioning their Health Economics and Outcomes Research (HEOR) function away from the Commercial organization to Medical Affairs. This has some major implications towards the interactions with key stakeholders, the way interactions are documented and the skill sets & activities that may be required. Development of strong health outcomes capabilities within Medical Affairs organizations requires an increase in that function’s involvement with health outcomes groups, development of field-based health outcomes capabilities, customization of health outcomes data by stakeholders and building real world data capabilities to generate and utilize health outcomes information.
Best Practices, LLC undertook this study to identify strategies to increase MA’s role in Health Outcomes data generation and utilization. Specifically, the study highlights the role of Medical Affairs function in HO activities, industry drivers and resource levels for HO groups, challenges of MA’s involvement in HO activities and strategies for effective HO data communication and utilization.
Download Full Report: http://bit.ly/2dGFAbz
This document summarizes a report that investigated student opinions and attitudes towards adding an Event Marketing minor to the Welch College of Business at Sacred Heart University. A survey and focus group were conducted. The results showed that over half of students were interested in event marketing as a career. The report concluded most students would enroll in the minor. It was recommended that the Welch College of Business offer this minor, as it would provide a competitive advantage for students and increase enrollments for the university. The minor would expand academic offerings and expertise for students.
1. The document analyzes whether Sacred Heart University's College of Business should offer a minor in event marketing.
2. It conducted a survey and focus group of Sacred Heart students to understand their interest and opinions on adding this minor.
3. The results found that over half (56.9%) of students were interested in event marketing as a career and minor. It was recommended that the college offer this minor given the clear student interest.
This document discusses the importance of research in business management and decision making. It provides several examples of how businesses use research, including testing new products, measuring advertising effectiveness, ensuring adequate distribution, studying competitors, and recruiting qualified employees. The document also explains that research helps businesses make informed decisions, identify customer needs and preferences, analyze industry trends, and evaluate processes for improved efficiency. Overall, the document emphasizes that research is vital for businesses of all sizes to gain insights, remain competitive, and make strategic decisions.
This document provides tips and strategies for successful research participant recruitment, with a focus on recruiting underrepresented populations. It emphasizes the importance of preparing early in the research process by setting realistic recruitment goals, understanding the target population's perspective and priorities, and developing community partnerships. Specific strategies discussed include tailoring communications and the study design to the population, using various platforms like social media for outreach, addressing potential barriers to participation, and maintaining high retention through ongoing communication and convenience. The document also provides examples of recruitment materials and study summaries.
Educating KOLs, Physicians, Patients, and Payers to support successful produc...Best Practices, LLC
The document discusses best practices for educating key stakeholders to support successful product launches. It finds that companies should:
1) Start thought leader engagement early, as early as pre-clinical trials, through communication, advisory boards, and developing long-term strategies.
2) Seed medical science liaisons in phase 3 trials and grow their numbers each subsequent year leading up to launch.
3) Oncology companies may be more willing to take risks with investigator-initiated trials earlier to explore new uses and populations.
The document discusses best practices for pharmaceutical companies in developing and managing relationships with key opinion leaders (KOLs) through medical science liaisons (MSLs). It provides insights from benchmarking research on the roles of MSLs at different stages of product development and lifecycles. Companies must determine MSL field force size based on factors like product lifecycle, thought leader coverage, and franchise objectives. Developing and maintaining KOL relationships is important for gathering market insights and competitive intelligence.
MARKETING RESEARCH PROJECT REPORT ON “LIQOUR HABITS AMONG MBA STUDENT”UTSAV KUNDU
This document provides a report on a marketing research project conducted on liquor habits among MBA students. It begins with an acknowledgment section thanking those who helped with the project. It then includes undertakings signed by the students and guide confirming details of the research. The table of contents outlines the following 9 chapters: introduction, literature review, research objectives, methodology, analysis and interpretation of findings, research findings, conclusion, suggestions, and bibliography. The research methodology discusses using a structured questionnaire, a sample size of 150 respondents, and data collection in Delhi and surrounding areas. The project aims to understand factors like brand preferences, reasons for choices, and frequency of smoking among executives.
Content Marketing Rules for Healthcare OrganizationsAIS Media, Inc.
This document summarizes a presentation on content marketing strategies for healthcare organizations. It discusses defining target personas and mapping the patient journey to determine relevant content types and frequency. The content marketing triad of personas, format, and frequency is introduced to help establish an effective strategy. Examples of healthcare organizations successfully using content are provided, highlighting the importance of this approach for patient engagement and search engine optimization.
Different hats, same needs: Marketing compliance from doctor’s office to boar...Prolifiq Software
This document discusses the need for good promotional practices across different constituencies in the healthcare industry. It begins by outlining what doctors, companies, and board members want, which is largely reliable information, sales, and avoiding issues. The document then provides four actionable strategies for implementing good promotional practices: 1) Transforming sales reps into information concierges, 2) Using content management systems, 3) Implementing good promotional practices, and 4) Forming and supporting initiatives to bridge information gaps. It emphasizes that good promotional practices protect all parties and should be systematically institutionalized.
Medical affairs department for small organizationDr. Zubair Ali
The document summarizes the drug development process and the role of medical affairs departments within pharmaceutical companies. It discusses the various phases of clinical drug trials from phase I to phase IV. It then outlines the structure and responsibilities of medical affairs, including clinical research, pharmacovigilance, medical information services, statistics management, and providing medical support to marketing and sales teams. A key part of medical affairs is the medical science liaison program which aims to educate medical professionals and support clinical trial recruitment through relationship building.
Integrating Behavioural Science in Government CommunicationMike Kujawski
This is a deck I created for my presentation at the International Government Communicators Forum (Sharjah, UAE) with a goal of helping government communicators move beyond “awareness building” and into actual behaviour change using a social marketing framework.
Developing Research Culture in Aid of Policy Formulation.pptxErwinPurcia2
The document discusses developing a research culture to influence policy formulation. It outlines that research aims to develop theories, improve products/processes, apply findings to problems, and influence decision making. Developing a research culture requires factors like supporting research impact, practices, collaboration, strategies, funding incentives and infrastructure. The studies reviewed aimed to determine faculty research capabilities and competencies. Results showed males publish more than females but were equal in other areas. Productivity did not differ by marital status or age but increased with higher academic rank. Developing a strong research culture considers the interaction of institutional functions, research paradigms, policies and leadership.
Updated day 2 part 1 -social marketing basics training slidesprogroup
The document provides an overview of a day 1 training review on social marketing. It includes an agenda with activities to recall what was covered on day 1, as well as introductions to social marketing concepts. The learning objectives are outlined which include distinguishing social marketing from other approaches and exposure to social marketing campaign examples. The document then delves into an activity to motivate behavior change followed by definitions and key aspects of social marketing such as the six core elements, audience orientation, segmentation, influencing behavior change and the marketing mix.
The Clinician's Role in Developing a Patient Experience StrategyRenown Health
Learn how clinicians and marketing consultants can work together to develop a patient experience strategy that enables team to work at the highest levels and achieve outstanding results.
The document outlines Public Health England's strategic marketing priorities and approach for 2014-2017. It discusses focusing marketing efforts locally, through partnerships, and ensuring activities are evidence-based and transparent. It also describes developing "on demand" digital public health products and allocating spending based on a new model that scores health topics on several impact factors. The approach will organize activities by lifestage, integrating with screening programs, and potentially restructuring some brands under a single national brand.
This document summarizes the findings of a study on the future of the insights function conducted with over 300 senior marketers and insights leaders.
There is a gap between how insights leaders see themselves and how senior marketers perceive the insights function. While insights leaders see themselves as strategic consultants or explorers, many senior marketers still view insights as behind-the-scenes data collectors. However, both groups agree that insights should play the role of strategic consultants or explorers. The document outlines three paths for insights to transform - through basic organizational changes, becoming more proactive innovators, or getting involved in top-level business decisions. Overall, there is an opportunity for insights to become drivers of brand growth if this perception gap can
This document summarizes the findings of a study conducted by the World Federation of Advertisers (WFA) and BrainJuicer Group PLC on the future of the insights function. Over 300 senior marketers and insights leaders from 94 large companies participated in the study.
The study found that while insights leaders see themselves as strategic advisors, less than a third of senior marketers are satisfied with insights and see the function more as data collectors. There is consensus that insights should play a more strategic role by integrating more closely with marketing and adopting new methods and ideas. However, some new methods are more popular with marketers than insights leaders, suggesting differences in priorities. The document outlines opportunities and challenges for insights to evolve and
Think Tank V Key Takeaways & Best PracticesJustin Barnes
Care Strategy, Care Collaboration, Innovation, Industry Disruptors & Social Determinants of Health best practices directly and unscripted from thought leaders on the front lines of healthcare
Harness digital platforms to accelerate R&D and drive proper adoptionSharpBrains
Pioneers in education, medicine and pharma discussed new data-rich approaches to help assess what works and what doesn’t, and for whom, accelerating R&D initiatives and proper adoption.
--Chair: Alvaro Fernandez, CEO & Editor-in-Chief of SharpBrains
--Richard Varn, Director of the Center for Advanced Technology and Neuroscience at Educational Testing Service (ETS)
--Dr. Brian Iacoviello, Director of Scientific Affairs at Click Therapeutics
--Dr. Gahan Pandina, Senior Director, Venture Leader at Janssen Research & Development
--Dr. Sarah Banks, Head of Neuropsychology at the Cleveland Clinic Lou Ruvo Center for Brain Health
Learn more at sharpbrains.com
The document summarizes key insights from a global patient-centricity survey conducted by The Aurora Project. The top 5 insights are:
1) Patient centricity is becoming important to the pharmaceutical industry's future but confidence in delivering is lagging, especially among patients.
2) Most pharmaceutical leaders want to learn more about how to be patient-focused.
3) The industry believes being patient-focused improves business outcomes like trust, engagement, and revenues.
4) Training, resources, measurement, and focus across all departments could be improved to better execute on patient-centric intentions.
5) When asked how their company could do better, common themes were engaging patients more, allocating more budget
The document summarizes insights from a global patient-centricity survey conducted by The Aurora Project. The top 5 insights are:
1) Patient centricity is becoming important to the pharmaceutical industry's future but confidence in delivering is lagging, especially among patients.
2) Most pharmaceutical leaders want to learn more about how to be patient-focused.
3) The industry believes being patient-focused improves business outcomes like trust, engagement, and revenues.
4) When asked how to better focus on patients, common themes were engaging patients, allocating more resources, improving measurement, training, and ensuring all departments are responsible.
5) The survey provides a benchmark for where the industry is now on
Smart Research Solutions specializes in custom market research, program evaluation, and data analysis to support decision-making for government, commercial, and nonprofit clients. It utilizes multiple qualitative and quantitative research methods and has experience engaging hard-to-reach populations. Services include market research, testing, analytics, multilingual data collection, human factors research, and advanced data analysis. The company has focus group facilities, large respondent panels, and a network of interviewers to enable rapid qualitative data collection. It is led by experts in various research fields and has provided services to numerous federal agencies, associations, and commercial clients.
This document discusses the role of a medical advisor in the pharmaceutical industry. It provides:
1) An overview of the medical advisor role, including requirements like advanced scientific training, strong communication skills, and the ability to build relationships.
2) Details on responsibilities like developing relationships with key opinion leaders, presenting clinical data, and providing medical input on product strategies.
3) Insights into what the role entails, such as traveling regularly to meet with healthcare providers and presenting research opportunities to them.
Business research methods are systematic activities undertaken to increase knowledge. Research is needed to make informed business decisions and solve problems. Good research is guided by a clear question or problem, has a specific plan, interprets data to resolve the issue, and is cyclical in nature. Decision support systems and business intelligence systems help managers make decisions by providing access to large data volumes and using analytical models to identify patterns and trends. These systems support a variety of decision processes without making the final decision.
Growing Bio-pharma Digital Marketing Impact by Digitizing Launch, Developing ...Best Practices
It has become quite crucial to identify the drivers of digital marketing performance excellence in the health care industry which will enable companies to gain valuable customer insights, build effective relationships, leverage online media, and maximize revenue.
Best Practices, LLC undertook this benchmarking research to provide critical insights into how savvy bio-pharma digital marketers are enhancing the medical and commercial potential of new products, improving alignment with brand teams, acquiring and training new digital marketers, managing service delivery for key programs and optimizing insource vs. outsource mix.
Download Full Report: http://bit.ly/2gnXrIu
Drive Growth and Profitability Through Strategic Pharmaceutical New Product P...Best Practices
This document summarizes a benchmarking study of new product planning structures and activities at 15 pharmaceutical and biotech companies. Key findings include:
- Global teams transition from planning to marketing earlier than regional teams.
- Global teams begin branding activities like naming in phase II, while regional teams start in phase III.
- Global teams value segmentation and positioning most, while regional teams value market research.
- Global new product planning is more centralized while regional structures are more hybrid.
More Related Content
Similar to Educating the Marketplace to Support Successful Diabetes Product Launches Report Summary
Educating KOLs, Physicians, Patients, and Payers to support successful produc...Best Practices, LLC
The document discusses best practices for educating key stakeholders to support successful product launches. It finds that companies should:
1) Start thought leader engagement early, as early as pre-clinical trials, through communication, advisory boards, and developing long-term strategies.
2) Seed medical science liaisons in phase 3 trials and grow their numbers each subsequent year leading up to launch.
3) Oncology companies may be more willing to take risks with investigator-initiated trials earlier to explore new uses and populations.
The document discusses best practices for pharmaceutical companies in developing and managing relationships with key opinion leaders (KOLs) through medical science liaisons (MSLs). It provides insights from benchmarking research on the roles of MSLs at different stages of product development and lifecycles. Companies must determine MSL field force size based on factors like product lifecycle, thought leader coverage, and franchise objectives. Developing and maintaining KOL relationships is important for gathering market insights and competitive intelligence.
MARKETING RESEARCH PROJECT REPORT ON “LIQOUR HABITS AMONG MBA STUDENT”UTSAV KUNDU
This document provides a report on a marketing research project conducted on liquor habits among MBA students. It begins with an acknowledgment section thanking those who helped with the project. It then includes undertakings signed by the students and guide confirming details of the research. The table of contents outlines the following 9 chapters: introduction, literature review, research objectives, methodology, analysis and interpretation of findings, research findings, conclusion, suggestions, and bibliography. The research methodology discusses using a structured questionnaire, a sample size of 150 respondents, and data collection in Delhi and surrounding areas. The project aims to understand factors like brand preferences, reasons for choices, and frequency of smoking among executives.
Content Marketing Rules for Healthcare OrganizationsAIS Media, Inc.
This document summarizes a presentation on content marketing strategies for healthcare organizations. It discusses defining target personas and mapping the patient journey to determine relevant content types and frequency. The content marketing triad of personas, format, and frequency is introduced to help establish an effective strategy. Examples of healthcare organizations successfully using content are provided, highlighting the importance of this approach for patient engagement and search engine optimization.
Different hats, same needs: Marketing compliance from doctor’s office to boar...Prolifiq Software
This document discusses the need for good promotional practices across different constituencies in the healthcare industry. It begins by outlining what doctors, companies, and board members want, which is largely reliable information, sales, and avoiding issues. The document then provides four actionable strategies for implementing good promotional practices: 1) Transforming sales reps into information concierges, 2) Using content management systems, 3) Implementing good promotional practices, and 4) Forming and supporting initiatives to bridge information gaps. It emphasizes that good promotional practices protect all parties and should be systematically institutionalized.
Medical affairs department for small organizationDr. Zubair Ali
The document summarizes the drug development process and the role of medical affairs departments within pharmaceutical companies. It discusses the various phases of clinical drug trials from phase I to phase IV. It then outlines the structure and responsibilities of medical affairs, including clinical research, pharmacovigilance, medical information services, statistics management, and providing medical support to marketing and sales teams. A key part of medical affairs is the medical science liaison program which aims to educate medical professionals and support clinical trial recruitment through relationship building.
Integrating Behavioural Science in Government CommunicationMike Kujawski
This is a deck I created for my presentation at the International Government Communicators Forum (Sharjah, UAE) with a goal of helping government communicators move beyond “awareness building” and into actual behaviour change using a social marketing framework.
Developing Research Culture in Aid of Policy Formulation.pptxErwinPurcia2
The document discusses developing a research culture to influence policy formulation. It outlines that research aims to develop theories, improve products/processes, apply findings to problems, and influence decision making. Developing a research culture requires factors like supporting research impact, practices, collaboration, strategies, funding incentives and infrastructure. The studies reviewed aimed to determine faculty research capabilities and competencies. Results showed males publish more than females but were equal in other areas. Productivity did not differ by marital status or age but increased with higher academic rank. Developing a strong research culture considers the interaction of institutional functions, research paradigms, policies and leadership.
Updated day 2 part 1 -social marketing basics training slidesprogroup
The document provides an overview of a day 1 training review on social marketing. It includes an agenda with activities to recall what was covered on day 1, as well as introductions to social marketing concepts. The learning objectives are outlined which include distinguishing social marketing from other approaches and exposure to social marketing campaign examples. The document then delves into an activity to motivate behavior change followed by definitions and key aspects of social marketing such as the six core elements, audience orientation, segmentation, influencing behavior change and the marketing mix.
The Clinician's Role in Developing a Patient Experience StrategyRenown Health
Learn how clinicians and marketing consultants can work together to develop a patient experience strategy that enables team to work at the highest levels and achieve outstanding results.
The document outlines Public Health England's strategic marketing priorities and approach for 2014-2017. It discusses focusing marketing efforts locally, through partnerships, and ensuring activities are evidence-based and transparent. It also describes developing "on demand" digital public health products and allocating spending based on a new model that scores health topics on several impact factors. The approach will organize activities by lifestage, integrating with screening programs, and potentially restructuring some brands under a single national brand.
This document summarizes the findings of a study on the future of the insights function conducted with over 300 senior marketers and insights leaders.
There is a gap between how insights leaders see themselves and how senior marketers perceive the insights function. While insights leaders see themselves as strategic consultants or explorers, many senior marketers still view insights as behind-the-scenes data collectors. However, both groups agree that insights should play the role of strategic consultants or explorers. The document outlines three paths for insights to transform - through basic organizational changes, becoming more proactive innovators, or getting involved in top-level business decisions. Overall, there is an opportunity for insights to become drivers of brand growth if this perception gap can
This document summarizes the findings of a study conducted by the World Federation of Advertisers (WFA) and BrainJuicer Group PLC on the future of the insights function. Over 300 senior marketers and insights leaders from 94 large companies participated in the study.
The study found that while insights leaders see themselves as strategic advisors, less than a third of senior marketers are satisfied with insights and see the function more as data collectors. There is consensus that insights should play a more strategic role by integrating more closely with marketing and adopting new methods and ideas. However, some new methods are more popular with marketers than insights leaders, suggesting differences in priorities. The document outlines opportunities and challenges for insights to evolve and
Think Tank V Key Takeaways & Best PracticesJustin Barnes
Care Strategy, Care Collaboration, Innovation, Industry Disruptors & Social Determinants of Health best practices directly and unscripted from thought leaders on the front lines of healthcare
Harness digital platforms to accelerate R&D and drive proper adoptionSharpBrains
Pioneers in education, medicine and pharma discussed new data-rich approaches to help assess what works and what doesn’t, and for whom, accelerating R&D initiatives and proper adoption.
--Chair: Alvaro Fernandez, CEO & Editor-in-Chief of SharpBrains
--Richard Varn, Director of the Center for Advanced Technology and Neuroscience at Educational Testing Service (ETS)
--Dr. Brian Iacoviello, Director of Scientific Affairs at Click Therapeutics
--Dr. Gahan Pandina, Senior Director, Venture Leader at Janssen Research & Development
--Dr. Sarah Banks, Head of Neuropsychology at the Cleveland Clinic Lou Ruvo Center for Brain Health
Learn more at sharpbrains.com
The document summarizes key insights from a global patient-centricity survey conducted by The Aurora Project. The top 5 insights are:
1) Patient centricity is becoming important to the pharmaceutical industry's future but confidence in delivering is lagging, especially among patients.
2) Most pharmaceutical leaders want to learn more about how to be patient-focused.
3) The industry believes being patient-focused improves business outcomes like trust, engagement, and revenues.
4) Training, resources, measurement, and focus across all departments could be improved to better execute on patient-centric intentions.
5) When asked how their company could do better, common themes were engaging patients more, allocating more budget
The document summarizes insights from a global patient-centricity survey conducted by The Aurora Project. The top 5 insights are:
1) Patient centricity is becoming important to the pharmaceutical industry's future but confidence in delivering is lagging, especially among patients.
2) Most pharmaceutical leaders want to learn more about how to be patient-focused.
3) The industry believes being patient-focused improves business outcomes like trust, engagement, and revenues.
4) When asked how to better focus on patients, common themes were engaging patients, allocating more resources, improving measurement, training, and ensuring all departments are responsible.
5) The survey provides a benchmark for where the industry is now on
Smart Research Solutions specializes in custom market research, program evaluation, and data analysis to support decision-making for government, commercial, and nonprofit clients. It utilizes multiple qualitative and quantitative research methods and has experience engaging hard-to-reach populations. Services include market research, testing, analytics, multilingual data collection, human factors research, and advanced data analysis. The company has focus group facilities, large respondent panels, and a network of interviewers to enable rapid qualitative data collection. It is led by experts in various research fields and has provided services to numerous federal agencies, associations, and commercial clients.
This document discusses the role of a medical advisor in the pharmaceutical industry. It provides:
1) An overview of the medical advisor role, including requirements like advanced scientific training, strong communication skills, and the ability to build relationships.
2) Details on responsibilities like developing relationships with key opinion leaders, presenting clinical data, and providing medical input on product strategies.
3) Insights into what the role entails, such as traveling regularly to meet with healthcare providers and presenting research opportunities to them.
Business research methods are systematic activities undertaken to increase knowledge. Research is needed to make informed business decisions and solve problems. Good research is guided by a clear question or problem, has a specific plan, interprets data to resolve the issue, and is cyclical in nature. Decision support systems and business intelligence systems help managers make decisions by providing access to large data volumes and using analytical models to identify patterns and trends. These systems support a variety of decision processes without making the final decision.
Similar to Educating the Marketplace to Support Successful Diabetes Product Launches Report Summary (20)
Growing Bio-pharma Digital Marketing Impact by Digitizing Launch, Developing ...Best Practices
It has become quite crucial to identify the drivers of digital marketing performance excellence in the health care industry which will enable companies to gain valuable customer insights, build effective relationships, leverage online media, and maximize revenue.
Best Practices, LLC undertook this benchmarking research to provide critical insights into how savvy bio-pharma digital marketers are enhancing the medical and commercial potential of new products, improving alignment with brand teams, acquiring and training new digital marketers, managing service delivery for key programs and optimizing insource vs. outsource mix.
Download Full Report: http://bit.ly/2gnXrIu
Drive Growth and Profitability Through Strategic Pharmaceutical New Product P...Best Practices
This document summarizes a benchmarking study of new product planning structures and activities at 15 pharmaceutical and biotech companies. Key findings include:
- Global teams transition from planning to marketing earlier than regional teams.
- Global teams begin branding activities like naming in phase II, while regional teams start in phase III.
- Global teams value segmentation and positioning most, while regional teams value market research.
- Global new product planning is more centralized while regional structures are more hybrid.
Best-in-Class Strategies to Develop Effective Medical Information GroupsBest Practices
Medical information groups within bio-pharmaceutical companies play a vital role in the management of publications and product inquiries during the commercialization of drugs.
However, recent regulatory changes in the industry have made it imperative for the Medical Affairs function to align its medical information activities with compliance requirements.
This Best Practices, LLC report establishes benchmarks on the critical requirements to create strong medical information groups. In particular, this report identifies best practices in internal collaboration, alignment of information activities with compliance requirements and the structure, leadership and resource levels required to develop best-in-class medical information groups.
Download Full Report: http://bit.ly/2ewac07
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...Best Practices
This document summarizes a study examining best practices for collaborating with patient advocacy groups. It provides an overview of the research methodology, participating companies, key findings and insights. Some of the main findings include: 1) there is no single best structure for patient advocacy groups, with companies taking decentralized, centralized and hybrid approaches; 2) social media and video platforms are increasingly important in patient education; and 3) transparency, aligning objectives, and trust are critical when working with advocacy groups on controversial therapies.
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Best Practices
The Medical Affairs function plays an important role in health outcomes (HO) information exchange between bio-pharmaceutical organizations and key external stakeholders.
Development of robust health outcomes capabilities within Medical Affairs function requires an increase in the function’s involvement with health outcomes groups, development of field-based health outcomes capabilities, customization of health outcomes data as per stakeholders’ needs, and building real world data capabilities to generate and utilize health outcomes information.
This benchmarking research from Best Practices, LLC is designed to assist companies focused on oncology therapies find better ways to develop effective health outcomes groups. It provides current data and best practices from Medical Affairs leaders with an oncology focus at leading bio-pharmaceutical companies.
Download Full Report: http://bit.ly/2e3sl9Q
Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...Best Practices
This document provides a summary of a benchmarking study conducted by Best Practices, LLC on medical education structures, resources, and activities at major biopharmaceutical companies. Some key findings include:
- Most companies (over 75%) take a centralized approach to organizing their medical education functions. Nearly half centralize in the US.
- Companies heavily rely on outsourcing, delegating 86% of program development and all program deployment to vendors.
- Respondents were primarily directors or senior directors of medical education functions, with some managers. Insights were drawn from leaders across various roles and geographies.
Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...Best Practices
Medical education programs play an important role in informing health care professionals about the safe and effective use of medical devices.
To probe emerging medical education trends in the device sector, Best Practices, LLC undertook benchmarking research. In particular, this study provides benchmarks on the proper size, structure, funding channels, staffing and investment for medical education groups.
Download Full Report: http://bit.ly/2bY2NZ8
Delays in the launch and execution of critical market research projects can slow down the decision-making process, resulting in missed opportunities and increased costs. Therefore, it is absolutely critical for bio-pharmaceutical companies to develop a tactical approach to expedite the market research approval process for quicker and more meaningful insights.
According to recent research by Best Practices, LLC, nearly three-quarters of the benchmarked study participants use review cycle time as a metric for determining if the market research approval process is functioning at an acceptable level. One tip that participants gave on how to control processes and to ensure high performance is to create checklists. Begin with checklists in pinch points that are most problematic, and then extend to entire process and operations. This report will help leaders to gain critical insights they need to compete successfully in a fast-changing market.
Download Full Report: http://bit.ly/2bfAhOc
Benchmarking Professional Medical Education Excellence StructuresBest Practices
This document summarizes a benchmarking study conducted by Best Practices, LLC on medical education structures, resources, and activities at large biopharmaceutical companies. Key findings include:
- Most companies take a centralized approach to medical education, located in their US market or headquarters country.
- Companies rely heavily on outsourcing, using vendors for 53% of program development and 58% of program delivery on average.
- Staffing is concentrated in North America, with an average of 5 FTEs and $3.23 million budget per FTE. Companies support an average of 170 CME and 98 non-CME programs annually.
Given the stringent regulatory requirements in the health care industry, it is important for bio-pharmal companies to develop innovative Risk Evaluation and Mitigation Strategies (REMS) plans during the commercialization of certain products to ensure an acceptable risk-to-benefit ratio.
This benchmark study published by Best Practices, LLC examines how companies develop and execute successful Risk Evaluation and Mitigation Strategies (REMS) plans for newly-approved drugs in the U.S. market. This study can help bio-pharma companies in creating successful REMS programs.
Download Full Report: http://bit.ly/2aOt5Id
Budget Allocation for a Successful Bio-Pharma Product LaunchBest Practices
Bio-Pharma companies can no longer afford to rely solely on past experiences when budgeting for a new product launch in today's fast-changing, highly competitive market. This comprehensive benchmark study by Best Practices, LLC investigates current costs as well as budget and staffing allocations required for a successful drug launch.
This study can help bio-pharma leaders to develop competitive launch and pre-launch activity budgets to ensure successful U.S. market entry for new products.
Download Full Report: http://bit.ly/2aMYron
Driving Performance Excellence in the Regulatory Affairs Function at Medical ...Best Practices
This document summarizes research from a benchmarking study of regulatory affairs practices at 32 leading medical device companies. Key findings include:
- Regulatory affairs structures are most commonly centralized, though some utilize decentralized or hybrid models. Larger companies tend towards more decentralized structures.
- Portfolio complexity, defined as the ratio of class III products, influences but does not solely determine staffing needs.
- On average, companies file over a dozen submissions annually with European regulators and over 60 submissions with Japanese regulators.
- Regulatory staff spend significant time (over 20% for most companies) managing change notices and documentation.
Disease Awareness Program Excellence: Structure, Timing, Activities & Investm...Best Practices
Bio-pharmaceutical companies use disease state awareness campaigns to disseminate unbranded information to external stakeholders such as physicians, patients and payers.
Best Practices, LLC undertook research to deliver benchmarks around the structure, timing, investment and activities for disease awareness programs.
Download Full Report: http://bit.ly/2a7CnUS
Library Services Benchmarks - Using Corporate Library Services in PharmaBest Practices
Libraries are custodians of invaluable information. The study - Library Services Benchmarks 2016: Corporate Library Services in the Pharmaceutical Industry published by Best Practices, LLC examines the trends and staffing benchmarks such as library staff per potential and actual users across companies providing access to library services across the bio-pharmaceutical space.
This study looks into staff with formal education level and the number of staff inside and outside the library who provide library services. This study can be used by bio-pharmaceutical companies to improve upon existing library services and staffing.
Download Full Report: http://bit.ly/29QZcbM
Effective Launch Training Practices for District Sales Managers: Optimize Per...Best Practices
Rising competition and access restrictions in the bio-pharmaceutical industry have made it critical for companies to prepare and measure the performance of their District Sales Managers (DMs) who oversee launch-related activities in the field.
Best Practices, LLC engaged 20 sales leaders from bio-pharmaceutical companies to establish benchmarks around the training and accountability of District Sales Managers at launch. Insights from this study will serve as a reference point for companies to evaluate their launch training programs for the sales force against industry benchmarks.
Download Full Report: http://bit.ly/29Gq68L
Best Practices in Creating Global Brand for New Products and Ensuring Alignme...Best Practices
In order to develop an effective global branding program for new bio-pharmaceutical products, it is important to ensure brand consistency across all functions and geographies.
Best Practices, LLC undertook research to gather benchmarks on key aspects of the global branding process, including activities, timing, positioning, key message development, regional alignment, agency utilization & cost and the tradename process.
Download Full Report: http://bit.ly/2a1XqUV
Benchmarking Advisory Board Management at Mid-Sized Pharmaceutical & Medical ...Best Practices
The document provides a summary of research conducted on benchmarking advisory board management practices at mid-sized pharmaceutical and medical device organizations. Key findings from surveying 35 executives at 29 companies include that mid-sized companies have more advisory board participants on average compared to other companies, prefer national participants for clinical advisory boards, and face challenges in selecting appropriate advisory board members and managing advisory boards. The research was conducted to identify best practices for advisory board structure, selection of participants, operations, costs, and challenges.
This presentation gives an insight into the membership benefits of Best Practices, LLC’s Medical Affairs Consortium. It also highlights some of the key benchmarks and best practices that emerged from Medical Affairs Consortium.
The Medical Affairs Consortium at Best Practices, LLC provides a dedicated platform to Medical Affairs Leaders to discuss top challenges, develop action oriented solutions, share best practices & lessons learned and explore current and future trends with regards to the Medical Affairs function and its interactions with other critical functions.
Topics for the Medical Affairs Consortium are usually determined by member requests. The Medical Affairs Consortium addresses three key areas:
• Building Strong Medical Affairs Capabilities
• Medical Affairs Launch Support Excellence
• Medical Affairs’ Critical Role in Health Economics & Outcomes Research
Benchmarking Advisory Board Management At Large Pharmaceutical And Medical De...Best Practices
Pharmaceutical advisory boards provide strategic inputs and guidance to organizations on various business aspects. However, successful advisory board management requires optimum investment in resources and operations. To maximize the return on investment it is important for pharmaceutical and medical device professionals to ensure that the quality of meetings and dialogue with advisory boards is excellent.
This research from Best Practices, LLC is designed for pharmaceutical and biotech executives seeking ways to best utilize the knowledge of advisory boards. Research findings provide benchmarks on the appropriate structure for various types of advisory boards, selection of advisory board participants, advisory board operational and resource benchmarks.
Developing High-Impact Communication Forms to Brief Senior Leaders: Optimizin...Best Practices
This document provides a summary of research on developing high-impact communication forms to brief senior leaders on competitive assessments and clinical development summaries. It describes the research methodology, which included surveys and interviews with leaders from 27 bio-pharma companies. Key findings include that executive briefs should be concise (5 pages or less), include general market insights as well as competitor insights, and be created for both new and existing products. Important elements to include are the condition treated, compound name, revenue projections, and probability of success. The document provides templates and recommendations for crafting impactful competitive landscape assessments and clinical development summaries.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.